At the Payer Exchange Summit V, sponsored by the Community Oncology Alliance (COA), 2 employer groups and a provider participated on a panel to provide practical insight into the extraordinary challenges and decisions faced by employers and employees with a cancer diagnosis.
With discussions around cancer care quality and cost, payers—either health plans or employers—are concerned with what it means for them and for the patient. At the Payer Exchange Summit V, sponsored by the Community Oncology Alliance (COA), held October 24-25, 2016, in Tyson’s Corner, Virginia, 2 employer groups and a provider participated on a panel to provide practical insight into the extraordinary challenges and decisions faced by employers and employees with a cancer diagnosis.
Panel participants included Alice McAbee, CEBS, CCP, SPHR, SHRM-SCP, DynCorp International; Marianne Fazen, PhD, Texas Business Group on Health; Barry Russo, The Center for Cancer & Blood Disorders.
“Cancer is a top condition that concerns employers, because of cost, the quality of care, and the complexity associated with managing the disease,” Fazen said. “Employers are interested in helping their employees. With our coalition, we want to talk about the entire journey for the employee patient and also for employers to have access to the patient information.” Fazen then shared a video of a stage production on the entire cancer journey, which she said helped make a very significant impact in getting the message across to their employees.
According to Fazen, the top 3 challenges for employees are cost, the quality of care, and supporting the employee who has cancer as they try to return to work and return to normalcy. “The employer needs to accommodate them at the workplace, providing options such as rest time, changing their job profile to avoid heavy lifting, etc.”
As the provider of care to the cancer patients, Russo presented another aspect of cancer care: the delivery of care itself. “One of the several challenges is the complexity of the delivery system. We have so many sub-networks, informing the patients of their care provider makes it difficult to keep patients informed,” he said. According to Russo, the preauthorization process can be a significant challenge to care delivery. “Having the patient wait 7-14 days to initiate therapy as we try to go through the hoops is difficult for us, in addition to what the patient endures as they wait,” he said. “Meeting an ideal timeframe is a big challenge. Our third challenge is getting connected to the employers to explain to them what the QOPI certification means and other aspects of care. So the coalition has provided us a great opportunity for this.”
“For us, curbing our healthcare costs impacts whether someone has a job next year,” McAbee said. “So while cost is important, we are struggling with whether our employee has the right care at the right time.” She added that even if the employee does not raise this concern, having an advocacy model at play ensures that employees and their families have adequate care.
Fazen is a firm believer in the potential of education programs to align the different issues faced by employees. “For example, we had one on precision medicine, and one of the benefit managers in attendance said that if this is so valuable, ‘How come my benefit plan does not offer precision medicine?’ It turned out that they did offer employees the option of genetic testing, but they were provided this information only if they asked. So that is a care gap…a communication gap,” Fazen said.
Russo said “We need to listen to what employers are looking for and what their needs are. We can also help employers create a checklist of things that employees might need once they are diagnosed with cancer.”
“Too often its easy for those in my role to lose sight of what patients and providers are looking for,” McAbee said. “So the answer is in the individual patient experience and being mindful of what they need.”
Fazen agreed and emphasized the important support that a nurse navigator can provide to the process. “Having a nurse navigator at the workplace who is a patient advocate and navigator can have a significant impact, as can a convenient site for drug administration,” she said. “Working with the coalition helps cross educate providers, payers, and employees on what options are available for the employee patients.”
“We have to start trusting each other for a better outcome for the patient, and a better outcome for the process of better outcome,” according to Russo. “And benefit literacy is extremely important for this. The continuous learning process is ultimately going to deliver a better product to the patient. Ultimately, we will be at risk as a provider, but we have to understand the pieces to deliver better on the care we provide,” he said.
Study Highlights Key RA-ILD Risk Factors, Urges Early Screening
November 20th 2024This recent study highlights key risk factors for rheumatoid arthritis–associated interstitial lung disease (RA-ILD), emphasizing the importance of early screening to improve diagnosis and patient outcomes.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Why Right Heart Catheterization Confirming PAH Diagnosis May Be Underperformed
November 20th 2024Professional guidelines say that when pulmonary arterial hypertension (PAH) is diagnosed, right heart catheterization should be performed, but a quarter of the time, it isn’t—so investigators set out to discover why.
Read More
OS Better With Belantamab Mafodotin Triplet vs Daratumumab in R/R MM
November 19th 2024The key secondary end point of overall survival (OS) was met in the DREAMM-7 trial of belantamab mafodotin (Blenrep; GSK) for the treatment of patients with relapsed/refractory multiple myeloma (R/R MM).
Read More